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ABSTRACT
Background: In the period 2003e2008, the regulatory
authorities issued several warnings restricting the use
of selective serotonin re-uptake inhibitors (SSRIs) in
paediatrics, in reaction to safety concerns regarding
the risk of suicidality. In this study, the SSRIs and
suicidality controversy serves as a template to analyse
the long-term publication trends regarding the benefit/
risk profile of medications. The aim is to ascertain
differences (in terms of numbers, categories and
timing) between negative and positive newspaper and
journal articles on SSRIs and suicidality and to
ascertain correlations between changes in the reports
and regulatory warnings.
Methods: A systematic review of scientific articles
(Embase) and the Netherlands (NL) and the UK
newspapers (LexisNexis) was performed between
2000 and 2010. Categorisation was done by ‘effect’
(related treatment effect), ‘type of article’ and ‘age
group’. The articles’ positive-to-negative effect ratio
was determined. Differences in distribution of effect
categories were analysed across sources, type of
article and age group using the ManneWhitney (two
subgroups) or KruskaleWallis test (three or more).
Findings: In total, 1141 articles were categorised: 352
scientific, 224 Dutch and 565 British newspaper
articles. Scientific articles were predominantly on
research and were positive, whereas newspaper
articles were negative (ratios¼3.50dscientific,
0.69dNL and 0.94dUK; p<0.001). Articles on
paediatrics were less positive in scientific journals and
more negative in newspapers (ratios¼2.29dscientific,
0.26dNL and 0.20dUK; p<0.001), while articles on
adults were positive overall (ratios¼10.0dscientific,
1.06dNL and 1.70dUK; p<0.001). In addition,
negative-effect reporting trends were exacerbated
following regulatory warnings and were generally
opinion articles, both in scientific journals and in
newspapers (2003/2004 and after 2007).
Interpretation: The authors found a positive
publication tendency inherent in journal research
articles. This apparent positive publication bias present
in scientific journals, however, does not seem to
prevent the dissemination of ‘bad’ news about
medications. The negative tendency present in Dutch
and British newspapers was perceivable in the
paediatrics group and during the warnings, indicating
that national news media have informed the public
about this international drug safety controversy on time.
INTRODUCTION
The news media are an important source
of information about therapeutic drugs
and health.1 Coverage varies from
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Open Access Research
communicating the benefits and risks of medications to
drug regulation and litigation, among others.2 3 Scien-
tific journals are a significant source of information for
journalists writing about medicine.4 However, this does
not necessarily mean that ‘good’ or ‘bad’ news about
medicines in the news media is determined by the
scientific literature.4 5 The good and bad news in both
news media and scientific and medical journals may be
in agreement but may also differ dramatically depending
on the situation.6 7
Healthcare providers and consumers alike seek
medical information from the news media and act on
it accordingly, changing their perceptions and behav-
iour.8 9 Coverage of medical news exemplifies how
information from the news media and scientific journals
can have a significant impact, yet be confusing.7 10 11
Most newspapers’ coverage studies of the benefits and
risks of medications, although valuable, are short-term
and lack a comparative perspective among countries.2 8 12
In this study, we analysed the long-term publication
trends regarding the benefit/risk profile of medications
in the context of the selective serotonin re-uptake
inhibitors (SSRIs) and suicidality controversy (see box 1)
from 2000 to 2010 in scientific journals and newspapers
in the Netherlands (NL) and in the UK. The aim is to
ascertain the differences (in terms of numbers, categories
and timing) between negative and positive newspaper
and scientific journal articles on SSRIs and suicidality.
METHODS
Time frame
Content analysis was performed on articles published in
the period January 2000 to December 2009, including
the period in which the regulatory warnings were
repeatedly enforced, that is, 2003/2004 and 2007.
Data sources
Scientific articles were extracted from Embase (compi-
lation of Medline and 2000 extra journals not covered by
Medline) using two sets of keywords, that is, first: ‘sero-
tonin uptake inhibitor’ NOT ‘serotonin noradrenalin
reuptake inhibitor’ AND ‘suicidal behavior’ or ‘auto-
mutilation’ or ‘aggression’ AND ‘depression’; and
second: ‘serotonin uptake inhibitor’ NOT ‘serotonin
noradrenalin reuptake inhibitor’ AND ‘suicide’. The
search was limited to ‘humans’ and ‘Dutch’ and
‘English’ language.
Newspaper articles were extracted using the Lexis-
Nexis database from a selection of high-circulation
newspapers in NL (n¼6) and in the UK (n¼4).
The newspapers analysed were De Telegraaf, Algemeen
Dagblad, De Volkskrant, NRC Handelsblad, Trouw and Het
Parool for NL and The Sun, Daily Mail, The Daily Telegraph
and The Times for UK. The newspapers’ circulation
figures (per country) covered 11% of each total resident
population.21 22 Search queries were performed in the
language of the papers (Dutch and English). Dutch
articles were retrieved using the terms ‘antidepressiv!’ or
‘anti-depressiv!’ or ‘SSRI!’ or ‘serotonine!’ AND ‘zelf-
moord!’ or ‘aggressi!’ or ‘geweld!’ or ‘kwaad!’ or ‘suicid!’
AND ‘depressi!’. British articles were extracted using the
terms ‘antidepress!’ or ‘anti-depress!’ or ‘SSRI!’ or
‘serotonin!’ AND ‘suicid!’ or ‘aggressi!’ or ‘violen!’ or
‘harm!’ AND ‘depressi!’.
Data classification
All articles addressing SSRIs, depression, suicidal
thoughts or suicide as the main topic were eligible for
analysis. If that was not the case, such an article was
categorised as ‘out of context’, for example, articles
reporting the use of SSRIs to treat premature ejaculation
or neuralgia. All scientific and newspaper articles were
analysed on the content of full-text, except for scientific
articles where the abstract information was regarded
as sufficient for categorisation. The ‘effect’, ‘type of
article’ and ‘age group’ categories were independently
determined for these articles by two researchers.
The ‘effect’ category was divided into positive, neutral
and negative. Articles reporting on positive therapeutic
outcomes with no mention of an association between
SSRIs and an increased risk on suicidal behaviour were
classified as positive. Consequently, articles affirmatively
reporting on the association between SSRI use and
suicidality, with no mention of positive therapeutic
outcomes, were classified as negative. Articles with
a balanced message (positive and negative effects) were
classified as neutral. The ‘type of article’ category was
defined within scientific journals as: case study
Box 1 The SSRIs and suicidality controversy
In the period 2003e2008, regulatory authorities (Food and
Drug Administration (FDA), Medicines and Healthcare
products Regulatory Agency (MHRA) and European Medi-
cines Agency (EMA), among others) issued several warn-
ings restricting the use of SSRIs in paediatrics, in reaction to
safety concerns regarding suicidal ideation.13e15 While
some scientists adulated the warnings, others expressed
their concerns about the implied consequences.16 17 The
safety issue arose following GlaxoSmithKline’s (GSK)
request for a 6-month market exclusivity extension with the
FDA for the use of paroxetine (an SSRI) to treat paediatric
depression in response to the Food and Drug Administra-
tion Modernization Act. Consequently, GSK submitted the
results from unpublished paediatric clinical data to the FDA.
Meanwhile, the BBC aired a documentary entitled ‘The
secrets of Seroxat’ on 13 October 2002 in which it was
alleged that internal documents of GSK showed that the
dissemination of trial data on paroxetine in childhood
depression was spun ‘to minimise any negative commercial
impact’.18 GSK was accused of underplaying the associa-
tion between SSRIs and suicidality. The ensuing worldwide
media exposure played a role in driving the SSRI suicide
controversy. In the process, confidence in the pharmaceu-
tical industry and regulatory authorities decreased signifi-
cantly.19 To date, the controversy remains unsettled, albeit
evidence also suggests that SSRIs are useful first-line
treatments for depression and most anxiety disorders but
exhaustive monitoring is recommended during the initiating
phase.20
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(represents a descriptive and intensive analysis of an
individual patient), research (comprehends study
results, such as RCTs (randomised clinical trials), meta-
analyses, observational studies (multiple patients), etc),
opinion (enclose articles, such as letters to an editor,
commentaries, replies, etc) and policy (comprehends
articles discussing regulatory-related topics, etc). The
definition of ‘type of article’ in newspapers was based on
the nature and elaboration of the news conveyed:
interview (comprehends articles where the journalist
questioned the interviewee to retrieve information),
opinion (comprises articles where the author or jour-
nalist portrayed his/her personal perspective), news
report (covers general articles with informative news or
general journalism), science journalism (comprehends
articles presenting scientific information or reports) and
policy (comprehends articles discussing regulatory-
related topics, such as reimbursement, change of indi-
cation, etc). Finally, the ‘age group’ category considered
adults (above 18 years old), paediatric (18 years old or
younger), both (adult and paediatric) or unspecified.
Scoring discrepancies between the two researchers
occurred in approximately 5% of all the articles. In
a case of discrepancy, the categorisation of the article in
question was settled by consensus.
Data analysis
The positive-to-negative ratio of the ‘effect’ category was
calculated (per source, ‘type of article’ and ‘age group’
categories). For the statistical analyses, the total count of
articles per category was used. Differences in distribution
of the ‘effect’ categories (positive, neutral and negative)
were analysed across the sources (Embase, Dutch and/or
the UK newspaper articles); type of article and age group
were analysed using the ManneWhitney (two
subgroups) or KruskaleWallis test (three or more).
Statistical significance was defined as p<0.05. Statistical
analyses were performed using SPSS software (release
V.18.0.3).
To assess the publication dynamics, the number of
articles (in scientific journals and/or in newspapers) was
plotted per year (2000e2010) and per category (effect,
type of article or age group).
RESULTS
A total of 1736 articles were retrieved based on the
predefined key word sets. Of these, 1141 articles were
fully categorised: 352 scientific, 224 Dutch newspaper
articles and 565 British newspaper articles (figure 1).
The characteristics of the articles are listed in table 1.
Publication patterns of the ‘effect’ category
Of all 1141 articles (scientific and newspapers), the
positive-effect category (39%) was significantly larger
than the negative-effect (31%) or the neutral-effect
category (30%; p<0.001). The differentiation of the
‘effect’ category by source showed that scientific journals
were predominantly positive (ratio ¼3.5), whereas Dutch
and British newspapers coverage of effect was mainly
negative (ratios¼0.69dNL and 0.94dUK, table 1).
Statistically significant differences were observed in
effect classification for scientific journals and newspa-
pers (both p<0.001) but not between NL and the UK
dailies (p¼0.116, table 2).
Although the overall coverage of effect was generally
positive in scientific journals, temporal changes were
observed in the positive-to-negative effect ratio per
year, indicating a less positive-effect trend during 2003/
2004 and after 2007. Newspaper reporting revealed
a similar trend as scientific journals. However, the
Figure 1 Scheme of the search process performed in the
scientific and medical literature and in the Netherlands (NL)
and the UK newspapers.
Table 1 Characteristics of the 1141 articles in NL and the
UK newspapers and in scientific journals (2000e2009)
Characteristics
Scientific
journals
(n[352)
NL
newspapers
(n[224)
UK
newspapers
(n[565)
Effect*
Positive 191 (54) 65 (29) 192 (34)
Neutral 106 (30) 66 (29) 169 (30)
Negative 55 (16) 93 (42) 204 (36)
Positive-to-
negative ratio
3.5 0.69 0.94
Type of article
Case study 13 (4) NA NA
Research 210 (60) NA NA
Opinion 121 (34) 25 (11) 107 (19)
Policy 8 (2) 11 (5) 10 (2)
Interview NA 38 (17) 77 (14)
News report NA 110 (49) 291 (52)
Science
journalism
NA 40 (18) 80 (14)
Age group
Adults 89 (25) 128 (57) 313 (55)
Paediatric 108 (31) 30 (13) 92 (16)
Both 80 (23) 32 (14) 66 (12)
Unspecified 75 (21) 34 (15) 94 (17)
*Statistically significant differences in effect classification were
observed between scientific journals and newspapers (p<0.001)
but not between NL and the UK dailies (p¼0.116).
NL, the Netherlands.
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positive-to-negative effect ratio per year in newspapers
shifted to the negative side from 2003 to 2005 and after
2007 (figure 2B).
Publication patterns of the ‘type of article’ category
Scientific journals published generally research articles
(60%), carrying a positive-effect message (ratio¼8.5,
table 2). To a lesser extent, scientific journals published
opinion articles (34%), which conveyed an overall posi-
tive-effect message (ratio¼1.2, table 2). However, scien-
tific opinion articles displayed major temporal changes
in the positive-to-negative effect ratio following regula-
tory warnings, showing more negative-effect articles.
Differences of ‘effect’ distributions related to ‘types of
article’ were statistically significant (p<0.001, table 2).
Newspapers published mainly news report articles
(50.5%) and carried an overall negative-effect message
(ratio¼0.5, table 2). A similar negative-effect trend was
measured in scientific journalism articles (ratio¼0.7).
Newspaper opinion articles also portrayed an overall
positive-effect message (ratio¼2.1), as observed for
opinion articles in scientific journals (ratio¼1.2, table 2).
Major temporal changes in the positive-to-negative
effect ratio of newspaper articles were visible in the
period of regulatory warnings (2002e2005 and
2007e2008, figure 2B). Differences between effect
distributions related to ‘types of article’ were statistically
significant in the accumulated newspaper articles group,
the UK newspaper articles (p<0.001) and NL newspaper
articles (p¼0.011).
Publication patterns of the ‘age group’ category
Scientific journals reported more frequently on paedi-
atrics (31%) than on adults (25%; p<0.001). Articles on
adults were notably more positive concerning effect
compared with paediatric articles (ratios¼10 and 2.3,
table 2).
Newspapers paid more attention to adults (56%) than
paediatrics (15%, table 1). Reporting trend for articles
on adults was primarily positive about effect, whereas
those on paediatrics were mainly negative (ratios¼1.5
and 0.2). Significant differences were found between
effect distributions in newspapers related to age group
(p<0.001). Reporting patterns between NL and the UK
dailies were comparable in all three categories (p¼0.116,
table 2).
Articles on paediatrics in scientific journals and in
newspapers displayed similar publication dynamics, that
is, a significant peak in 2004, following the warnings. The
publication dynamics of articles on adults in scientific
Table 2 Allocation of effect categories related to types of article and age groups and differentiated by source (NL and the UK
newspaper articles combined)
Categories Positive Neutral Negative
Positive-to-
negative ratio p Value
NL newspapers 65 66 93 0.69 0.116
UK newspapers 192 169 204 0.94
Scientific journals 191 106 55 3.50 <0.001
NL and UK newspapers (mixed) 257 235 297 0.86
Type of article
Scientific journals
Case study 4 4 5 0.80 <0.001
Research 144 49 17 8.47
Opinion 39 49 33 1.18
Policy 3 5 0 3.00
Newspapers*
Interview 69 30 16 4.31 <0.001
News report 88 125 188 0.47
Science journalism 38 30 52 0.73
Opinion 60 43 29 2.07
Policy 2 7 12 0.17
Age group
Scientific journals
Adults 70 12 7 10.0 <0.001
Paediatric 48 39 21 2.29
Both 33 29 18 1.83
Unspecified 40 26 9 4.44
Newspapers
Adults 176 145 120 1.47 <0.001
Paediatric 18 20 84 0.21
Both 22 33 43 0.51
Unspecified 41 37 50 0.82
*Statistically significant differences in effect distributions related to types of article were also observed in the UK newspaper articles (p<0.001)
and in NL newspaper articles (p¼0.011).
NL, the Netherlands.
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journals and newspapers also showed a similar pattern.
Thereafter, newspaper articles on adults continued to
increase until 2010, while their scientific counterparts
remained more or less stable (figure 3).
DISCUSSION
This study assessed the characteristics and dynamics of
SSRIs and suicidality coverage by scientific and medical
journals in general and newspapers in NL and the UK
from 2000 to 2010. Scientific journals published
predominantly research articles about positive thera-
peutic outcomes with little mention of an association
between SSRIs and suicidality, particularly in adults.
Despite different ethnic backgrounds (eg, tabloid culture
in the UK, among others) and language, newspaper
reporting trends in NL and the UK were comparable and
were overall negative regarding the therapeutic effect of
SSRIs in paediatrics, while positive-effect reporting
prevailed for adults.
The present study has several limitations. It covered
11% of the total population per country based on
newspaper circulation figures. Nevertheless, the random
sample is representative (n¼789 newspaper articles)
given the aim to ascertain differences (in terms of
numbers, categories and timing) between negative and
positive newspaper and journal articles on SSRIs
and suicidality. The categories ‘effect’ and ‘type of
article’ might be limited by our definition, and their
interpretation could differ between readers. We
attempted to avoid subjectivity by analysing the data
independently by two researchers. We achieved >95%
agreements during article categorisation (effect, type of
article and age group categories). We did not, however,
ascertain the context of the articles in terms of
construction of the newspaper and opinion articles from
its original source. Neither did we explore other forms of
media coverage (television, radio, magazines or the
internet). The content analysis method used in this
Figure 2 (A) Effect messages
(positive and negative) organised
along the research period, per
year (2000e2009) and according
to the source (scientificemedical
journals and newspapers). (B)
The natural logarithm of the
positive-to-negative ratio was
calculated and also plotted for the
accumulated scientificemedical
articles (green line), accumulated
newspaper articles (red line) and
solely research articles from the
scientificemedical literature (dark
blue line). *The grey zone
illustrates the period where most
of the regulatory warnings were
issued. **Articles with a positive-
effect trend are located above
zero, while articles conveying
a negative-effect trend are located
underneath zero.
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study does not allow for these additional more complex
queries.
Our results showing a positive publication tendency in
scientific journals are consistent with the previous work,
which demonstrated that antidepressant trials with a posi-
tive outcome were published more often than those with
negative outcomes.23 This positive publication tendency
continued even after the regulatory warnings and could
potentially leave physicians with a biased view of the
medications that they are prescribing to patients. Studies
questioning these warnings and the possible disservice
they did to public health (eg, the possible inverse associ-
ation between SSRIs prescriptions and suicidality or the
decline in treatment of depression in paediatrics)
contributed to this post-warning positive-effect trend.16 17
On the other hand, this positive publication tendency in
scientific journals does not seem to prevent the dissemi-
nation of bad news about medications. For instance,
science journalism articles (newspapers) that presented
a negative publication tendency regarding SSRIs
(ratio¼0.7) could not be related to the positive publica-
tion tendency found in scientific journals. These findings
indicate that either newspaper journalists may selectively
report scientific outcomes to the public, as also stated in
the CHMP assessment report on antidepressants,24 or that
controversial topics might be selected to increase reader-
ship.4 10 25 26 Such practices might generate confusion,
since the translation of evidence-based medicine to the
public is not uniform,2 5 12 27 and may have implications
for patients compliance with medications, willingness to
see physicians and trust in the doctorepatient relation-
ship. However, scientific and medical journals might also
do disfavour to the scientific community by favouring
positive outcome studies, thus limiting the journalists’
sources of accurate and critic information to communi-
cate to the public new scientific and medical evidence.
The uncertainties regarding the SSRIs’ benefit/risk
balance, primarily in paediatrics, have led to the restric-
tion of almost all SSRIs under 18-year-olds in 2003 and
further restrictions for young adults (18e24-year-old) in
2007.13e15 28 In the same periods, our data revealed shifts
towards negative-effect reporting trends in scientific and
newspaper articles on paediatrics and opinion articles.
The timing between the warnings and the observed
increase in articles substantiate the possible influence of
warnings on media publication trends. Moreover, this
increment in the number of articles suggests that news-
papers informed the public about this particular drug
safety event in a timely fashion. Studies have underlined
the relevance of informing the public about medical
news within a suitable time frame.6 29 However, these
studies only focused on a subset of scientific journals,
whereas we did not discriminate among scientific jour-
nals. A balance between timely coverage, consistent and
adequate information is fundamental when reporting on
drug safety controversies. Ideally, this balance should be
the result of an open dialogue between healthcare
practitioners, academia, governmental agencies, the
pharmaceutical industry, journalists and the public.
However difficult, educating the public properly and on
time about the benefits and the risks of medicines will
help to maintain public trust during unsettling periods.30
Finally, the possible implications of the discovered
tendencies in scientific journals and newspapers for
patients and doctors have not been addressed in this
paper. It has been shown that news media reports (on
suicide or related to suicide) have an influence on
suicidal behaviour and on drug usage.31 32 It might be
valuable in this regard to determine the long-term
influence of media coverage and the regulatory warnings
on prescription patterns.
CONCLUSIONS
Our study of the SSRIs and suicidality controversy
showed several publication tendencies in scientific jour-
nals and newspapers. We identified a positive publication
Figure 3 Articles indexed into
age groups (paediatric and adult)
in scientificemedical journals and
in newspapers from 2000 to 2009.
The scale of newspaper articles
on adults is portrayed on the right
y-axis. *The grey zone illustrates
the period where most of the
regulatory warnings were issued.
PaediatricPaediatric
6 Hernandez JF, Mantel-Teeuwisse AK, van Thiel GJMW, et al. BMJ Open 2011;1:e000290. doi:10.1136/bmjopen-2011-000290
Publication trends in newspapers and scientific journals for SSRIs and suicidality
tendency inherent in journal research articles, which
could potentially affect doctors’ assessment of the safety
and effectiveness of the medications that they are
prescribing to patients. This apparent positive publica-
tion bias in scientific journals, however, does not seem to
prevent the dissemination of bad news about medica-
tions. The occurrence of good or bad news in scientific
journals and newspapers was found to be dependent on
the news category or type of article. Opinion reports in
scientific journals did not differ significantly in the
nature and timing of reporting from opinion articles in
Dutch and British dailies. Differences between the Dutch
and British newspaper reporting patterns were minor.
The negative tendency present in Dutch and British
newspapers was perceivable in the paediatrics group and
during the warnings, indicating that newspapers have
informed the public about this drug safety controversy
on time. It also shows that a proactive and transparent
risk communication strategy of regulatory offices
and the pharmaceutical industry might pay off in the
long run for reporting on the benefits and risks of
medications.
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